Search Results 71-80 of 936 for 广州高效过滤器厂家,耐高温高效空气过滤器厂家,耐高温高效过滤器价格,医用高效空气过滤器,中效袋式过滤器,咨询电话:13560190937 李经理,网址:ggrhgc.cn

1. chronic obstructive pulmonary disease Archives - Mayo Clinic News Network

2. Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma - Mayo Clinic

   The primary objective of the study is to evaluate the effect of 3 dose levels of MEDI9929 (AMG 157) on asthma exacerbations in adult subjects with inadequately ...

3. An Extension Study to Evaluate the Long-Term Safety of QGE031 in Chronic Spontaneous Urticaria Patients from a Previous Study - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. Global Utilization and Registry Database for Improved Preservation of Donor Lungs - Mayo Clinic

   The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor lung that were preserved ...

5. Collaborators - Gut Microbiome Laboratory - Mayo Clinic Research

   The Gut Microbiome Lab led by Purna C. Kashyap, M.B.B.S., collaborates with researchers at Mayo Clinic and across the country.

6. Publications - Holly L. Geyer, M.D. - Mayo Clinic

   Geyer H. Are America's Schools Prepared for an Overdose? American School Board Journal (Accepted). 2024. Dugani SB, Fischer KM, Schroeder DR, Geyer HL, ...

7. Faculty and staff - Aspirin-Exacerbated Respiratory Disease: Elina Jerschow - Mayo Clinic Research

   View a list of faculty and staff in the Aspirin-Exacerbated Respiratory Disease Laboratory of Elina Jerschow, M.D., M.S., at Mayo Clinic.

8. AZD5305 Vs Placebo In Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors - Mayo Clinic

   About this study. This is an open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetic (what the body does to the drug), ...

10. Videos - Gut Microbiome Laboratory - Mayo Clinic Research

    View videos about the research and educational information based on the findings of Mayo Clinic's Gut Microbiome Lab.